Cyclic analogs of alpha-MSH fragments
|
patent
|
October 1997 |
Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
|
patent
|
April 2019 |
Therapeutic Radiopharmaceuticals
|
journal
|
September 1999 |
Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targeting
|
patent
|
October 2016 |
Gonadotropin-releasing hormone receptor-targeting peptides and their use to treat and diagnose cancer
|
patent
|
November 2015 |
Evaluation of the Human Melanoma Targeting Properties of Radiolabeled α-Melanocyte Stimulating Hormone Peptide Analogues
|
journal
|
October 2003 |
Yttrium-90-labelled somatostatin-analogue for cancer treatment
|
journal
|
February 1998 |
Evaluation of a 99mTc-Labeled Cyclic RGD Tetramer for Noninvasive Imaging Integrin αvβ3-Positive Breast Cancer
|
journal
|
March 2007 |
Impact of PKM Linkers on Biodistribution Characteristics of the 99mTc-Labeled Cyclic RGDfK Dimer
|
journal
|
November 2006 |
Design of a new class of superpotent cyclic .alpha.-melanotropins based on quenched dynamic simulations
|
journal
|
April 1989 |
Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models
|
journal
|
September 2002 |
Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
|
patent
|
December 2013 |
Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases
|
journal
|
February 2000 |
Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide
|
journal
|
January 2007 |
Design of cyclic and other templates for potent and selective peptide α-MSH analogues
|
journal
|
August 2005 |
Alpha-melanocyte stimulating hormone peptide-targeted melanoma imaging
|
journal
|
January 2007 |
Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues
|
journal
|
August 2006 |
In vivo evaluation of188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy
|
journal
|
September 2002 |
Microimaging Characterization of a B16-F10 Melanoma Metastasis Mouse Model
|
journal
|
April 2006 |
Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
|
patent
|
November 2016 |
[half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity.
|
journal
|
March 1982 |
Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
|
patent
|
March 2015 |
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
|
journal
|
August 2001 |
Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
|
patent
|
April 2015 |
Method of Inducing Melanogenesis in Humans With Mc1R Variant Alleles
|
patent-application
|
January 2008 |
Specific Receptors for α-Melanocyte-Stimulating Hormone Are Widely Distributed in Tissues of Rodents
|
journal
|
November 1987 |
Melanoma Therapy via Peptide-Targeted -Radiation
|
journal
|
August 2005 |
Potent and prolonged-acting cyclic lactam analogs of .alpha.-melanotropin: design based on molecular dynamics
|
journal
|
December 1989 |
64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor v 3 Integrin Expression
|
journal
|
July 2007 |
111In-Labeled Lactam Bridge-Cyclized α-Melanocyte Stimulating Hormone Peptide Analogues for Melanoma Imaging
|
journal
|
January 2008 |
Cancer Statistics, 2007
|
journal
|
January 2007 |
Tumor-targeting properties of 90Y- and 177Lu-labeled α-melanocyte stimulating hormone peptide analogues in a murine melanoma model
|
journal
|
July 2005 |
Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
|
patent
|
August 2018 |
Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targeting
|
patent
|
March 2019 |
Metastatic melanoma imaging with an 111In-labeled lactam bridge-cyclized α-melanocyte-stimulating hormone peptide
|
journal
|
April 2009 |
DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy
|
journal
|
July 1997 |
Design and characterization of -melanotropin peptide analogs cyclized through rhenium and technetium metal coordination
|
journal
|
October 1998 |
In Vitro and In Vivo Characterization of Indium-111 and Technetium-99m Labeled CCK-8 Derivatives for CCK-B Receptor Imaging
|
journal
|
February 2004 |
Molecular imaging of gene expression and protein function in vivo with PET and SPECT
|
journal
|
September 2002 |
Molecular imaging of cancer with positron emission tomography
|
journal
|
September 2002 |
Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
|
patent
|
November 2019 |
Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
|
patent
|
July 2016 |
Metastasis Results from Preexisting Variant Cells Within a Malignant Tumor
|
journal
|
August 1977 |
Improved targeting of the αvβ3 integrin by multimerisation of RGD peptides
|
journal
|
August 2006 |
Imaging of Melanoma Using 64Cu− and 86Y−DOTA−ReCCMSH(Arg11), a Cyclized Peptide Analogue of α-MSH
|
journal
|
March 2005 |